查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2012508

胜肽合成市場：依產品類型、技術、應用和最終用戶分類－2026-2032年全球市場預測

Peptide Synthesis Market by Product Type, Technology, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，胜肽合成市場價值將達到 7.5389 億美元，到 2026 年將成長至 8.1194 億美元，到 2032 年將達到 13.0228 億美元，複合年成長率為 8.12%。

主要市場統計數據
基準年 2025 7.5389億美元
預計年份：2026年 8.1194億美元
預測年份 2032 13.0228億美元
複合年成長率 (%) 8.12%

透過全面、前瞻性的實施，我們將為下一代胜肽合成奠定基礎。

肽合成已成為現代生物技術的基石，推動了治療、診斷和研究應用領域的突破性進展。化學和酶合成技術的進步使得肽序列能夠以前所未有的速度和精度進行精確組裝，從而加速了學術實驗室、受託研究機構和製藥公司的創新。現今的胜肽合成領域以自動化平台、高通量工作流程和先進純化系統的整合為特徵，所有這些都是為了滿足藥物開發平臺和分析實驗室的嚴苛要求而設計的。

識別將重新定義胜肽合成並提高現代行業標準的變革性技術和市場變化。

肽合成領域正經歷一場變革，主要得益於自動化合成平台的快速發展。這使得研究人員能夠以驚人的精度生成複雜的胜肽鏈。如今，高通量合成儀採用模組化設計和即時監控功能，圖了合成週期並提高了重現性。這些創新與利用高效液相層析法和先進樹脂的精密純化系統相輔相成，能夠提供符合治療藥物研發嚴格標準的超高純度胜肽。

分析 2025 年美國關稅調整對胜肽合成供應鏈和產業趨勢的累積影響。

2025年，美國關稅政策的調整對胜肽合成供應鏈產生了累積影響，尤其對層析法設備、冷凍乾燥機以及關鍵試劑等主要製造地的進口造成了衝擊。關稅的進一步調整增加了某些組件的到貨成本，迫使各機構重新審視其籌資策略。許多實驗室正透過供應商多元化、尋求區域性夥伴關係關係以及加快國內設備供應商的認證流程來應對這項挑戰，以降低關稅波動帶來的風險。

關鍵的細分見解揭示了胜肽合成在產品、技術、應用和最終用戶方面的不同面向。

胜肽合成市場涵蓋多種產品類型，主要類別包括儀器、試劑和耗材以及服務。儀器包括純化所必需的層析法設備、用於溫和乾燥胜肽的先進凍乾機以及支援自動化偶聯和去保護循環的尖端合成設備。試劑和耗材涵蓋所有構建模組和載體，從氨基酸和專用耦合試劑到螢光標記染料和高性能樹脂，每種都對序列準確性和下游分析起著至關重要的作用。為了完善這些產品線，服務供應商提供分析測試、客製化胜肽生產和法規制定的專業知識，確保合成工作流程的無縫銜接。

該分析深入探討了主要地區的展望，揭示了美洲、歐洲、中東和非洲以及亞太地區的趨勢和成長要素。

胜肽合成領域的區域趨勢凸顯了美洲、歐洲、中東和非洲以及亞太地區的獨特優勢和新興機會。在美洲，北美是創新核心中心，這得歸功於強大的學術合作以及製藥領域研發的集中投入。拉丁美洲正經歷著穩步擴張，這主要得益於對本地契約製造的投資以及對生物製藥研發日益成長的關注。

揭示胜肽合成領域創新和領導地位的主要企業的競爭格局和策略概況。

胜肽合成領域的競爭格局呈現出設備製造商、試劑供應商和專業服務機構並存的局面。主要設備供應商不斷透過模組化設計、雲端監控和人工智慧驅動的製程控制來改進其合成平台，以滿足多樣化的研發和生產需求。領先的試劑供應商則透過提供高純度胺基酸、胜肽合成試劑盒和創新偶聯化學品來拓展產品線，同時優先考慮永續性，採用生物基溶劑和可回收樹脂。

透過切實可行的建議推動產業轉型：幫助相關人員克服複雜局面，最大限度地掌握新機會。

為克服胜肽合成的複雜性，產業領導者應優先投資自動化和數位化，以提高生產效率並最大限度地減少人為錯誤。與新興技術供應商建立策略夥伴關係，可獲得專業的合成平台和新型化學反應；而合作研究夥伴關係則可加速治療和診斷應用領域的創新。同時，企業應透過供應商關係多元化、從多個地區採購關鍵試劑以及整合先進的物流解決方案來增強供應鏈的靈活性，從而建立一個穩健的採購系統。

詳細介紹了支持對肽合成這一多方面領域進行深入研究的嚴謹調查方法和分析框架。

本分析整合了嚴謹的調查方法所得出的結果，結合了來自一手調查和二手調查的洞見。一手調查包括對學術機構、受託研究機構和生物製藥公司的意見領袖、合成科學家和採購專家進行詳細訪談。二手調查則全面查閱了同行評審的學術期刊、專利資料庫、監管文件、技術規範和公司披露信息，以檢驗新趨勢和技術進步。

全面而策略性的考量，為胜肽合成的發展演變和未來方向提供了一致的視角。

總之，胜肽合成領域的特點是技術快速發展、監管環境不斷變化以及競爭格局瞬息萬變。自動化、混合合成平台和數位分析技術的進步提高了效率，並為基於胜肽的治療和診斷開闢了新的可能性。創新生態系統和供應鏈韌性的區域差異凸顯了策略在地化和跨境合作的重要性。同時，關稅調整和永續發展要求正在重塑籌資策略和流程最佳化的優先事項。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 胜肽合成市場：依產品類型分類

  • 裝置
    • 層析法裝置
    • 冷凍乾燥機
    • 胜肽合成裝置
  • 試劑和耗材
    • 胺基酸
    • 耦合試劑
    • 染料和螢光標記試劑
    • 樹脂
  • 服務

第9章 胜肽合成市場：依技術分類

  • 混合技術
  • 液相胜肽合成
  • 固相胜肽合成

第10章 胜肽合成市場：依應用領域分類

  • 化妝品
  • 診斷
  • 研究與開發
  • 治療藥物

第11章 胜肽合成市場：依最終用戶分類

  • 學術研究
  • 臨床實驗室
  • 合約研究機構
  • 製藥和生物技術公司

第12章 胜肽合成市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 胜肽合成市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 胜肽合成市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國胜肽合成市場

第16章：中國胜肽合成市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 2B Scientific Limited
  • AAPPTec LLC
  • ABclonal, Inc.
  • Advanced ChemTech by Thorn BioScience LLC
  • Almac Group Limited
  • AmbioPharm Inc.
  • AnaSpec Inc.
  • Bachem AG
  • Biocon Limited
  • BioDuro LLC
  • Biosynth Ltd.
  • Biotage AB
  • CEM Corporation
  • CPC Scientific Inc.
  • Creative Diagnostics
  • Creative Peptides
  • CSBio Sciences Private Limited
  • Enamine Ltd.
  • GenScript Biotech Corporation
  • Gyros Protein Technologies AB by Mesa Laboratories, Inc.
  • JPT Peptide Technologies GmbH by TheraCode GmbH
  • Kaneka Corporation
  • LifeTein LLC
  • Merck KGaA
  • New England BioGroup, LLC
  • Novo Nordisk A/S
  • PolyPeptide Group AG
  • Thermo Fisher Scientific Inc.
  • USV Private Limited
Product Code: MRR-431388EE3B9B

The Peptide Synthesis Market was valued at USD 753.89 million in 2025 and is projected to grow to USD 811.94 million in 2026, with a CAGR of 8.12%, reaching USD 1,302.28 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 753.89 million
Estimated Year [2026] USD 811.94 million
Forecast Year [2032] USD 1,302.28 million
CAGR (%) 8.12%

Establishing the Foundation for Next-Generation Peptide Synthesis Through a Comprehensive and Forward-Looking Introduction

Peptide synthesis has emerged as a cornerstone of modern biotechnology, driving breakthroughs in therapeutics, diagnostics, and research applications. Advances in chemical and enzymatic synthesis techniques have enabled precise assembly of peptide sequences with unprecedented speed and fidelity, fueling innovation across academic laboratories, contract research organizations, and pharmaceutical companies. Today's peptide synthesis landscape is marked by the integration of automation platforms, high-throughput workflows, and advanced purification systems, all designed to meet the rigorous demands of drug development pipelines and analytical laboratories.

Against this backdrop, the industry is witnessing a convergence of multidisciplinary insights spanning synthetic chemistry, biophysics, and data science. The marriage of machine learning algorithms with peptide design tools is accelerating the discovery of novel bioactive molecules while enhancing process optimization and cost efficiency. Moreover, the growing emphasis on sustainable practices has catalyzed the adoption of green chemistry principles in reagent selection and waste reduction, aligning with broader environmental and regulatory imperatives.

As peptide therapeutics continue to gain traction in areas such as oncology, infectious disease, and metabolic disorders, stakeholders across the value chain are pursuing strategic partnerships to expand capabilities, secure supply chains, and navigate complex regulatory landscapes. Increasing collaboration between instrument manufacturers, reagent suppliers, and service providers is reshaping the ecosystem, fostering innovation hubs and specialized contract facilities dedicated to peptide production. Collectively, these developments underscore the dynamic evolution of peptide synthesis and set the stage for the deeper exploration of technological, economic, and regional factors that follow in this report.

Identifying Transformative Technological and Market Shifts Redefining Peptide Synthesis and Elevating Industry Standards in the Modern Era

The peptide synthesis sector is undergoing transformative shifts driven by rapid advancements in automated synthesis platforms, enabling researchers to produce complex peptide chains with remarkable precision. High-throughput synthesizers now incorporate modular designs and real-time monitoring features, reducing cycle times and enhancing reproducibility. These innovations are complemented by sophisticated purification systems that leverage high-performance liquid chromatography and advanced resins to deliver peptides with exceptional purity, meeting the stringent standards required for therapeutic development.

Equally impactful is the rise of hybrid technologies that blend solid-phase and liquid-phase approaches, providing unparalleled flexibility for synthesizing a diverse range of peptides, including long sequences and modified analogs. Such hybrid systems streamline workflows by integrating coupling, deprotection, and cleavage steps into seamless processes. This convergence of methodologies is further amplified by digitalization initiatives, where laboratory information management systems and AI-driven analytics facilitate predictive maintenance, yield optimization, and adaptive synthesis protocols based on historical performance data.

Regulatory landscapes are evolving in parallel, with agencies worldwide refining guidelines for peptide therapeutics and associated manufacturing practices. This regulatory clarity is fostering greater confidence among stakeholders and catalyzing investment in large-scale peptide production facilities. As a result, the competitive dynamics of the peptide synthesis market are shifting, with established players and new entrants alike racing to differentiate through specialized offerings, strategic alliances, and value-added services that cater to emerging therapeutic targets and diagnostic applications.

Unpacking the Cumulative Impact of United States Tariff Adjustments in 2025 on Peptide Synthesis Supply Chains and Industry Dynamics

In 2025, adjustments to United States tariff policies have exerted a cumulative impact on the peptide synthesis supply chain, particularly affecting imports of chromatography instruments, lyophilizers, and critical reagents from key manufacturing hubs. The rebalancing of duties has led to increased landed costs for certain components, prompting organizations to reassess sourcing strategies. Many laboratories have responded by diversifying supplier portfolios, seeking alternative regional partnerships, and accelerating qualification processes for domestic equipment vendors to mitigate exposure to tariff fluctuations.

At the same time, reagent manufacturers and consumable suppliers have faced pressure to absorb or offset tariff-related cost increases, leading some to renegotiate contracts and introduce value-engineered reagent lines. Service providers in contract research and manufacturing have also adapted their pricing models, incorporating surcharges and longer lead times to account for supply chain uncertainties. While these adjustments have introduced complexity into procurement cycles, they have concurrently spurred the development of resilient sourcing frameworks and closer collaboration between end users and suppliers to maintain continuity of operations in peptide synthesis workflows.

Gleaning Key Segmentation Insights to Illuminate Diverse Dimensions of Peptide Synthesis Spanning Products Technologies Applications and End Users

The peptide synthesis market encompasses a diverse array of product types, with core categories including equipment, reagents & consumables, and services. Equipment spans chromatography instruments essential for purification, advanced lyophilizers for gentle drying of peptides, and state-of-the-art synthesizers that support automation of coupling and deprotection cycles. Reagents and consumables cover the full spectrum of building blocks and supports, from amino acids and specialized coupling reagents to dyes for fluorescent labeling and high-performance resins, each playing a critical role in sequence fidelity and downstream analysis. Complementing these tangible offerings, service providers deliver analytical testing, custom peptide production, and method development expertise, ensuring seamless integration of synthesis workflows.

Technological segmentation further highlights distinctions among hybrid platforms that blend solid-phase and liquid-phase chemistries, dedicated liquid-phase peptide synthesis systems for long-chain peptides, and solid-phase instruments optimized for rapid cycle synthesis of shorter sequences. Each technology pathway addresses specific application requirements, balancing throughput, peptide length capacity, and customization flexibility.

Applications of peptide synthesis extend across cosmetics, where bioactive peptides rejuvenate skin and hair treatments; diagnostic assays that leverage labeled peptides for biomarker detection; research and development efforts in drug discovery; and therapeutic modalities that harness peptide-based drugs for targeted treatment. End users range from academic research institutions pioneering novel peptide designs to clinical laboratories conducting biomarker validation, from contract research organizations offering turnkey peptide synthesis services to pharmaceutical and biotechnology companies advancing peptide therapeutics from concept to clinic. This multi-dimensional segmentation underscores the nuanced requirements and value drivers tailored to each segment of the peptide synthesis ecosystem.

Delving into Key Regional Perspectives Uncovering Trends and Growth Drivers Across Americas Europe Middle East Africa and the Asia Pacific

Regional dynamics within peptide synthesis reveal unique strengths and emerging opportunities across the Americas, Europe, Middle East & Africa, and Asia-Pacific domains. In the Americas, North America serves as a central hub for innovation, bolstered by robust academic collaborations and a high concentration of pharmaceutical R&D initiatives. Latin America is witnessing gradual expansion, driven by investments in local contract manufacturing and a growing emphasis on biopharmaceutical development.

Europe maintains leadership in regulatory harmonization and quality standards, with Western Europe at the forefront of advanced research intensification. The Middle East & Africa region is experiencing early-stage growth, supported by government initiatives to enhance biotechnology capabilities and develop local manufacturing capacities. Meanwhile, Asia-Pacific stands out as a dynamic frontier, where countries such as China, India, Japan, and South Korea are scaling up peptide synthesis infrastructure, driven by cost-effective manufacturing, government research budgets, and a burgeoning base of biotech startups.

Across these regions, collaborative networks are strengthening, with cross-border partnerships enabling technology transfer, capacity expansion, and shared expertise. This regional interplay shapes procurement strategies, influences regulatory compliance pathways, and redefines competitive positioning for global and local players in the peptide synthesis arena.

Unlocking Key Company Competitor Landscapes and Strategic Profiles That Drive Innovation and Leadership within the Peptide Synthesis Sector

The competitive landscape in peptide synthesis features a blend of instrumentation manufacturers, reagent suppliers, and specialized service organizations. Leading instrument vendors are continuously enhancing synthesis platforms with modular designs, cloud-enabled monitoring, and AI-driven process controls to meet diverse research and production needs. Key reagent suppliers are expanding their portfolios with high-purity amino acids, peptide synthesis kits, and innovative coupling chemistries, while prioritizing sustainability through bio-based solvents and recyclable resins.

Specialized service providers have carved out strategic niches by offering end-to-end peptide manufacturing, from custom sequence design to bulk production and analytical support. Contract research organizations are strengthening their capabilities with dedicated pilot-scale facilities and rigorous quality management systems to expedite the transition of peptide leads into clinical development. Across the board, strategic partnerships, licensing agreements, and targeted acquisitions are enabling companies to broaden their reach, integrate complementary technologies, and accelerate time to market. These concerted efforts reflect the intense drive toward differentiation through value-added services, regulatory expertise, and robust supply chain resilience in the global peptide synthesis sector.

Transforming Industry Trajectories with Actionable Recommendations Empowering Stakeholders to Navigate Complexities and Capitalize on Emerging Opportunities

Industry leaders seeking to navigate the complexities of peptide synthesis should prioritize investments in automation and digitalization to boost throughput and minimize human error. Establishing strategic alliances with emerging technology providers can unlock access to specialized synthesis platforms and novel chemistries, while collaborative research partnerships can accelerate innovation across therapeutic and diagnostic applications. Concurrently, companies should enhance supply chain agility by diversifying vendor relationships, sourcing critical reagents from multiple geographies, and integrating advanced logistics solutions for resilient procurement.

Sustainability initiatives must be embedded throughout peptide production workflows, including adoption of green solvents, recycling programs for consumables, and continuous process optimization to reduce energy consumption. Strengthening capabilities in regulatory intelligence will ensure timely alignment with evolving guidelines, expediting approval pathways and market entry. Finally, talent development strategies that focus on interdisciplinary skill sets-spanning synthetic chemistry, analytical science, and data analytics-will position organizations to harness technological innovation and capitalize on emerging opportunities within the peptide synthesis ecosystem.

Detailing Rigorous Research Methodology and Analytical Frameworks Underpinning Insights in the Multifaceted Domain of Peptide Synthesis

This analysis integrates insights derived from a rigorous research methodology that combines primary and secondary data sources. Primary research involved in-depth interviews with thought leaders, synthesis scientists, and procurement specialists across academic institutions, contract organizations, and biopharma companies. Secondary research encompassed a thorough review of peer-reviewed journals, patent databases, regulatory filings, technical specifications, and corporate disclosures to validate emerging trends and technological advancements.

Analytical frameworks underpinning this study include SWOT assessments to evaluate internal strengths and external threats, PESTLE analysis to contextualize macro-environmental factors, and Porter's Five Forces to gauge competitive intensity. Market segmentation mapping provided granular visibility into product categories, technology platforms, applications, and end-user perspectives. Quality assurance measures such as data triangulation, cross-verification of sources, and expert peer reviews ensured the credibility and reliability of findings. This structured approach delivers a comprehensive and nuanced understanding of the peptide synthesis landscape.

Concluding Reflections and Strategic Considerations Providing a Cohesive Outlook on the Evolution and Future Direction of Peptide Synthesis

In conclusion, the peptide synthesis sector is characterized by rapid technological evolution, shifting regulatory frameworks, and dynamic competitive landscapes. Advances in automation, hybrid synthesis platforms, and digital analytics are driving efficiency and unlocking new possibilities for peptide-based therapeutics and diagnostics. Regional variations in innovation ecosystems and supply chain resilience underscore the importance of strategic localization and cross-border collaboration. Meanwhile, tariff adjustments and sustainability imperatives are reshaping procurement strategies and process optimization priorities.

By synthesizing segmentation insights with company profiles and actionable recommendations, this analysis equips decision-makers with a holistic view of the landscape. Staying attuned to emerging trends, investing in advanced technologies, and fostering agile, sustainable operations will be critical for organizations aiming to maintain leadership in the peptide synthesis arena. The insights presented herein offer a clear roadmap for navigating current challenges and capitalizing on the transformative potential of peptide science.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peptide Synthesis Market, by Product Type

  • 8.1. Equipment
    • 8.1.1. Chromatography Equipment
    • 8.1.2. Lyophilizers
    • 8.1.3. Peptide Synthesizers
  • 8.2. Reagents & Consumables
    • 8.2.1. Amino Acids
    • 8.2.2. Coupling Reagents
    • 8.2.3. Dyes & Fluroscent Labeling Reagents
    • 8.2.4. Resins
  • 8.3. Services

9. Peptide Synthesis Market, by Technology

  • 9.1. Hybrid Technology
  • 9.2. Liquid Phase Peptide Synthesis
  • 9.3. Solid Phase Peptide Synthesis

10. Peptide Synthesis Market, by Application

  • 10.1. Cosmetics
  • 10.2. Diagnosis
  • 10.3. Research & Development
  • 10.4. Therapeutics

11. Peptide Synthesis Market, by End-User

  • 11.1. Academic Research
  • 11.2. Clinical Laboratories
  • 11.3. Contract Research Organizations
  • 11.4. Pharmaceutical & Biotech Companies

12. Peptide Synthesis Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Peptide Synthesis Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Peptide Synthesis Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Peptide Synthesis Market

16. China Peptide Synthesis Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 2B Scientific Limited
  • 17.6. AAPPTec LLC
  • 17.7. ABclonal, Inc.
  • 17.8. Advanced ChemTech by Thorn BioScience LLC
  • 17.9. Almac Group Limited
  • 17.10. AmbioPharm Inc.
  • 17.11. AnaSpec Inc.
  • 17.12. Bachem AG
  • 17.13. Biocon Limited
  • 17.14. BioDuro LLC
  • 17.15. Biosynth Ltd.
  • 17.16. Biotage AB
  • 17.17. CEM Corporation
  • 17.18. CPC Scientific Inc.
  • 17.19. Creative Diagnostics
  • 17.20. Creative Peptides
  • 17.21. CSBio Sciences Private Limited
  • 17.22. Enamine Ltd.
  • 17.23. GenScript Biotech Corporation
  • 17.24. Gyros Protein Technologies AB by Mesa Laboratories, Inc.
  • 17.25. JPT Peptide Technologies GmbH by TheraCode GmbH
  • 17.26. Kaneka Corporation
  • 17.27. LifeTein LLC
  • 17.28. Merck KGaA
  • 17.29. New England BioGroup, LLC
  • 17.30. Novo Nordisk A/S
  • 17.31. PolyPeptide Group AG
  • 17.32. Thermo Fisher Scientific Inc.
  • 17.33. USV Private Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PEPTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PEPTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY LYOPHILIZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY LYOPHILIZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY LYOPHILIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE SYNTHESIZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE SYNTHESIZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE SYNTHESIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY AMINO ACIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY AMINO ACIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUPLING REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUPLING REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUPLING REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY DYES & FLUROSCENT LABELING REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY DYES & FLUROSCENT LABELING REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY DYES & FLUROSCENT LABELING REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY RESINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY RESINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY RESINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY HYBRID TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY HYBRID TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY HYBRID TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY LIQUID PHASE PEPTIDE SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY LIQUID PHASE PEPTIDE SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY LIQUID PHASE PEPTIDE SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SOLID PHASE PEPTIDE SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SOLID PHASE PEPTIDE SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SOLID PHASE PEPTIDE SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COSMETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COSMETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COSMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CLINICAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CLINICAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 136. GCC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GCC PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. GCC PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 139. GCC PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 140. GCC PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. GCC PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. GCC PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 157. G7 PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. G7 PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. G7 PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 160. G7 PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 161. G7 PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. G7 PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. G7 PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 164. NATO PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. NATO PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NATO PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 167. NATO PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 168. NATO PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. NATO PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. NATO PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA PEPTIDE SYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)